Keyphrases
Alternative Therapy
16%
Antibiotic Development
16%
Antimicrobial Photodynamic Therapy (aPDT)
100%
Bacterial Growth
16%
Bimetallic
16%
Carbapenemase
16%
Cefepime
33%
Clinic Isolates
16%
Cytotoxicity
16%
Dark Toxicity
16%
Effective Treatment
100%
Extended-spectrum beta-lactamase Producers
33%
Extended-spectrum beta-lactamase-producing Klebsiella Pneumoniae
100%
Extended-spectrum β-lactamase
33%
HEK293 Cells
16%
HepG2 Cells
16%
High Risk
16%
Human Health Risk
16%
Imipenem
33%
Killing Bacteria
16%
Klebsiella Pneumoniae (K. pneumoniae)
83%
KPC-producing Klebsiella Pneumoniae
16%
Lactams
100%
Lethality
16%
Light Exposure
16%
Light-dependent
16%
Low Cytotoxicity
16%
Low Light
16%
Mammalian Cells
33%
Minimum Effective Dose
16%
Multidrug-resistant Bacteria
16%
New Antibiotics
16%
Oxidative Stress
16%
Photodynamic Effect
100%
Photon Flux
16%
Photooxidative Stress
16%
Photosensitizer
50%
Positive Control
16%
Ru(II) Complexes
16%
Synergism
100%
Synergistic Antibacterial
16%
Synergistic Effect
33%
Therapy Effect
33%
Toxicity in Vitro
16%
Trypan Blue Assay
16%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotic Agent
16%
Antiinfective Agent
100%
Beta Lactam
100%
Carbapenemase
16%
Cefotaxime
33%
Cytotoxicity
33%
Extended Spectrum Beta Lactamase
66%
Extended Spectrum Beta Lactamase Producing Klebsiella Pneumoniae
100%
Imipenem
33%
In Vitro Toxicity
16%
Klebsiella pneumoniae
16%
Lethality
16%
Photodynamic Therapy
100%
Photosensitizer
50%
Synergism
100%
Trypan Blue
16%
Immunology and Microbiology
Bacterial Growth
14%
Bactericidal Activity
14%
Cytotoxicity
28%
Extended Spectrum Beta Lactamase Producing Klebsiella Pneumoniae
100%
Klebsiella pneumoniae
14%
Light Exposure
14%
Oxidative Stress
14%
Photodynamics
100%
Synergism
100%